Pol Boudes
Overview
Pol Boudes received an average of $1M in total compensation, including $365K in salary, at Cymabay Therapeutics from 2014 to 2019.
Source: SEC filings on May 15, 2020, April 26, 2019, April 20, 2018, April 19, 2017, and April 21, 2015.
Related executives
We found nine more executives who work or worked at Cymabay Therapeutics.
Sujal Shah
Cymabay Therapeutics
Chief Executive Officer
Charles McWherter
Cymabay Therapeutics
President of R&D
Paul Quinlan
Cymabay Therapeutics
General Counsel
Dennis Kim
Cymabay Therapeutics
Chief Medical Officer
Lewis Stuart
Cymabay Therapeutics
Chief Commercial Officer
Janet Dorling
Cymabay Therapeutics
Former Chief Commercial Officer
Klara Dickinson
Cymabay Therapeutics
Chief Regulatory and Compliance Officer
Daniel Menold
Cymabay Therapeutics